The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases

Neurological Sciences

Volumn 31, Issue SUPPL. 3, 2010, Pages

  Bruno, Valeria ^a,b   Battaglia, Giuseppe ^b   Nicoletti, Ferdinando ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Biological drugs monoclonal antibodies autoimmune diseases multiple sclerosis

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; PATHOLOGY; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CHRONIC DISEASE; HUMANS; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 84856384340     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-010-0382-6     Document Type: Conference Paper

References (14)

1. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256:495-497
2. Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contact. Cell 94:667-677 (Pubitemid 28427585)
3. Huppas JB, Davis MM (2003) T-cell-antigen recognition and the immunological synapse. Nat Rev Immunol 3:973-983
4. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678-688
5. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393-407
6. McLaughin KA, Wucherpfennig KW (2008) B cells and auto-antibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol 98:121-149
7. Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel J-F (2008) Crohn's disease: beyond antagonists of tumor necrosis factor. Lancet 372:67-81 (Pubitemid 351902263)
8. Jones JL, Phuah CL, Cox AL, Thompson SA, Ban M, Shawcross J, Walton A, Sawcer SJ, Compston A, Coles AJ (2009) IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H). J Clin Invest 119:2052-2061
9. Binder M, Vögtle F-N, Michelfelder S, Müller F, Illerhaus G, Sundararajan S, Mertelsmann R, Trepel M (2007) Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab. Cancer Res 67:3518-3523 (Pubitemid 46762130)
10. Edwards JC, Cambridge G (2006) B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6:394-403
11. Steinman L (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 9:440-447
12. Carson KR, Focosi D, Major EO, Petrini E, Richey EA, West DP, Bennet CL (2009) Monoclonal antibody-associated progressive multifocal leukoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816-824
13. Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271-285
14. Descotes J (2009) Immunotoxicity of monoclonal antibodies. MAbs 1:104-111